Evidence map›Paper›PMID 30741371›Full record

ArticleDrugs & aging2019

EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.

L J Seppala, N van der Velde, T Masud, H Blain, M Petrovic, T J van der Cammen, K Szczerbińska, S Hartikainen, R A Kenny, J Ryg and 23 more

Abstract read
In one paragraph

Article in Drugs & aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Multidimensional determinants of active and healthy aging trajectories: a position paper from the Age-It Research Program.The journals of gerontology. Series B, Psychological sciences and social sciences · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Postural Control Characteristics in Alzheimer's Disease, Dementia With Lewy Bodies, and Vascular Dementia.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

L J SeppalaDepartment of Internal Medicine, Section of Geriatric Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
N van der VeldeDepartment of Internal Medicine, Section of Geriatric Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. n.vandervelde@amc.uva.nl.
T MasudNottingham University Hospitals NHS Trust, Nottingham, UK.
H BlainDepartment of Internal Medicine and Geriatrics, University Hospital of Montpellier, Montpellier University, Euromov, France.
M PetrovicDepartment of Internal Medicine (Geriatrics), Ghent University, Ghent, Belgium.
T J van der CammenFaculty of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands.
K SzczerbińskaUnit for Research on Aging Society, Department of Sociology of Medicine, Epidemiology and Preventive Medicine Chair, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
S HartikainenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
R A KennyThe Irish Longitudinal Study on Ageing (TILDA), Trinity College Dublin, Dublin 2, Ireland.
J RygDepartment of Geriatric Medicine, Odense University Hospital, Odense, Denmark.
P EklundDepartment of Computing Science, Umeå University, Umeå, Sweden.
E TopinkováDepartment of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
A MairEffective Prescribing and Therapeutics, Health and Social Care Directorate, Scottish Government, Edinburgh, Scotland, UK.
L LaflammeDepartment of Public Health Sciences, Karolinska Institutet, Tomtebodavägen 18A, Widerströmska huset, 17177, Stockholm, Sweden.
H ThalerTrauma Center Wien-Meidling, Kundratstrasse 37, 1120, Vienna, Austria.
G BahatIstanbul Medical School, Department of Internal Medicine, Division of Geriatrics, Istanbul University, Capa, 34093, Istanbul, Turkey.
M Gutiérrez-ValenciaDepartment of Health Sciences, Public University of Navarra (UPNA), Avda, Barañain s/n, 31008, Pamplona, Spain.
M A Caballero-MoraServicio de Geriatría, Hospital Universitario de Getafe and CIBER de Fragilidad y Envejecimiento Saludable, Getafe, Madrid, Spain.
F LandiDepartment of Gerontology, Neuroscience and Orthopedics, Catholic University of the Sacred Heart, Rome, Italy.
M H Emmelot-VonkDepartment of Geriatrics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
EuGMS Task and Finish Group on  Fall-Risk-Increasing Drugs
A CherubiniGeriatria, Accettazione geriatrica e Centro di ricerca per l'Invecchiamento, Italian National Research Center on Aging (INRCA), Ancona, Italy.
J P BaeyensUniversity of Luxembourg, Ezch-sur-Alzette, Luxembourg.
A Correa-PérezServicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
A GudmundssonLandspitali University Hospital, Reykjavik, Iceland.
A MarengoniDepartment of Clinical and Experimental Science, University of Brescia, Brescia, Italy.
D O'MahonyDepartment of Geriatric Medicine, Cork University Hospital, Cork, Ireland.
N ParekhAcademic Department of Geriatric Medicine, Brighton and Sussex Medical School, Brighton, Sussex, UK.
F E PisaDepartment of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
C RajkumarDepartment of Elderly Medicine, Brighton and Sussex University Hospitals NHS Trust, Sussex, UK.
M WehlingInstitute of Clinical Pharmacology Mannheim, University of Heidelberg, Heidelberg, Germany.
G ZiereDepartment of Internal Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
EuGMS Special Interest Group on Pharmacology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Falls are a major public health concern in the older population, and certain medication classes are a significant risk factor for falls. However, knowledge is lacking among both physicians and older people, including caregivers, concerning the role of medication as a risk factor. In the present statement, the European Geriatric Medicine Society (EuGMS) Task and Finish group on fall-risk-increasing drugs (FRIDs), in collaboration with the EuGMS Special Interest group on Pharmacology and the European Union of Medical Specialists (UEMS) Geriatric Medicine Section, outlines its position regarding knowledge dissemination on medication-related falls in older people across Europe. The EuGMS Task and Finish group is developing educational materials to facilitate knowledge dissemination for healthcare professionals and older people. In addition, steps in primary prevention through judicious prescribing, deprescribing of FRIDs (withdrawal and dose reduction), and gaps in current research are outlined in this position paper.

Indexed as

Accidental FallsAgedAged, 80 and overAge FactorsAnalgesics, OpioidAnticonvulsantsEuropeEuropean UnionGeriatricsHumansPolypharmacyPsychotropic DrugsRisk FactorsSodium Potassium Chloride Symporter InhibitorsAnalgesics, OpioidAnticonvulsantsPsychotropic DrugsSodium Potassium Chloride Symporter Inhibitors

Identifiers

PMID30741371
PMCPMC6435622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.